Publications by authors named "Ana Patricia Batista Mesquita Sauvage"
Thromb Haemost
October 2023
Article Synopsis
- Emicizumab is a bispecific antibody used to treat hemophilia A, but typical coagulation tests can't accurately measure its effects due to over-correction.
- This study involved six adult patients receiving emicizumab, where their treatment response was monitored through thrombin generation (TG) and fibrin clot formation (FCF) over several weeks.
- Results indicated that TG and FCF improved significantly with treatment, suggesting that these global coagulation assays could serve as valuable indicators of emicizumab's effectiveness and contribute to more personalized treatment plans.
